Related Experiment Video
Updated: Jun 24, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
Development of the rubella vaccine and vaccination strategy in Japan
1Seinan Jo Gakuin University, Kitakyushu, Japan.
Insights
Japan
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Japan's rubella vaccination program has a unique history.
- Initial strategies involved schoolgirl vaccination and later childhood MMR vaccination.
Purpose of the Study:
- To outline the evolution of rubella vaccination strategies in Japan.
- To highlight the impact of vaccination program changes on rubella and congenital rubella syndrome elimination goals.
Main Methods:
- Review of historical vaccination policies and licensed rubella vaccines in Japan.
- Analysis of vaccination program changes and their timeline.
Main Results:
- Rubella vaccination for schoolgirls began in 1977.
- A measles-mumps-rubella (MMR) vaccine program (1989-1993) was halted due to aseptic meningitis.
- Monovalent rubella vaccination resumed in 1994, followed by a two-dose combined measles and rubella (MR) vaccine program in 2006.
Conclusions:
- Japan's adaptive vaccination strategies reflect a commitment to controlling rubella.
- The implementation of a two-dose MR vaccine program offers a strong path towards rubella and congenital rubella syndrome elimination.
Abstract:
The development of the rubella vaccine and vaccination strategy in Japan was unique. Five rubella vaccines used in Japan were licensed, and the rubella vaccine program to schoolgirls was started in 1977. The measles-mumps-rubella vaccination to children which started in 1989, was terminated in 1993 due to the adverse effect of aseptic meningitis. In 1994, rubella vaccination to children, using the monovalent rubella vaccine, was restarted. Then, a new vaccination program, vaccinating twice by using the combined measles and rubella vaccine, was started in 2006. The increase in the rate of vaccination leads us to hope for the "Elimination of Rubella and Congenital Rubella Syndrome in 2012".
Related Concept Videos
Smallpox
Respiratory Syncytial Virus Disease
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Poliomyelitis
Vaccines

